A company built around one cell type family, from isolation through culture to genetic modification.
Eynos LifeScience is the brand of Eynos (Nanjing) LifeScience Co., Ltd., a company focused on immune-cell separation, immune-cell culture and differentiation, and gene regulation. The product range is deliberately narrow: it covers one cell type family — immune cells — from isolation through culture to genetic modification.
Cell separation. Magnetic separation reagents for human and mouse T cells, B cells, NK cells, monocytes, macrophages, dendritic cells, neutrophils and haematopoietic progenitors, in both column-free negative-selection and column-based nanobead formats. A BD FACSAria™ III cell sorter supports custom separation work.
Activation and differentiation. CD3/CD28 activation beads, functional antibodies and cytokines, and Treg / Th1 / Th2 / macrophage / dendritic-cell differentiation kits, with the media and buffers that go with them.
Gene and editor delivery. Envelope-engineered and targeted viral delivery systems for primary immune cells — the step where resting T cells and haematopoietic progenitors usually resist transfection.
Manufacturing and R&D: Building B, Light of Life, 114 Longshan South Road, Jiangbei New Area, Nanjing, Jiangsu, China.
Office: Room 205-8, Building A-4, Shuwu 16, 73 Tanmi Road, Jiangbei New Area, Nanjing, Jiangsu, China.
Founded 23 September 2024. Unified social credit code 91320191MADYFYUL9N.
The scope is vertical rather than broad: one cell type family, one workflow, with reagents and services built against the same protocols. When a customer reports a result, we publish it with the sample, the gate strategy and the caveats — including the cases where a number should not be extrapolated.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.